The United Laboratories International Holdings Limited 配当情報
The United Laboratories International Holdings Limited は1株あたり年間配当金が 0.06 で、利回りは 0.00% です。配当金は 半年ごと に支払われ、最後の除息日は Sep 25, 2025 でした。
配当利回り
年間配当
除権日
0.00%
$0.06
Sep 25, 2025
支払い頻度
支払率
半年ごと
0.00%
配当履歴
除権日
現金額
記録日
支払日
Sep 25, 2025
$0.1751
Sep 26, 2025
Oct 15, 2025
Jul 8, 2025
$0.3066
Jul 9, 2025
Jul 23, 2025
Jul 8, 2025
$0.1314
Jul 9, 2025
Jul 23, 2025
Sep 19, 2024
$0.1763
Sep 20, 2024
Oct 15, 2024
Jul 2, 2024
$0.3073
Jul 3, 2024
Jul 24, 2024
Jul 2, 2024
$0.1317
Jul 3, 2024
Jul 24, 2024
配当チャート
ULIHF 配当
ULIHF 配当成長率(年間比)
Follow-Up Questions
The United Laboratories International Holdings Limitedの現在の配当金と年間配当金はいくらですか?
The United Laboratories International Holdings Limitedが現在支払う配当金は$0.1751です。The United Laboratories International Holdings Limitedの年間配当金は$0.06です。
The United Laboratories International Holdings Limitedの配当性向は何ですか?
The United Laboratories International Holdings Limitedの配当性向は0.00%です。
ULIHFの配当落ち日はいつですか?
The United Laboratories International Holdings Limitedの配当落ち日はSep 25, 2025です。
The United Laboratories International Holdings Limitedはどのくらいの頻度で配当金を支払いますか?
四半期ごと。The United Laboratories International Holdings Limitedが最後に配当金を支払ったのはOct 15, 2025です。
主要データ
前終値
$1.24
始値
$1.3
当日レンジ
$1.24 - $1.3
52週レンジ
$1.17 - $2.27
取引高
1.0K
平均取引高
298
配当利回り
--
1株当たり利益(TTM)
0.16
時価総額
$2.4B
UNITED LABORATORIES INTL HLDGS とは何ですか?
The United Laboratories International Holdings Ltd. is an investment company, which engages in manufacturing and selling medicine products. The company employs 18,000 full-time employees The company went IPO on 2007-06-15. The firm operates its business through three segments. The Intermediate Products segment is engaged in the sale of intermediate products. The Bulk Medicine segment is engaged in the sale of bulk medicine. The Finished Products segment is engaged in the sale of antibiotics finished products, non-antibiotics finished products and capsule casings. Through its subsidiaries, the Company is also engaged in the production and sale of organic fertilizer.